Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats - Wikidata - wikimedia - TriplyDB

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats

http://www.wikidata.org/entity/Q34818322

about

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.G Protein-Coupled Receptor Heteromers.Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function.Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay.The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo.Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder.A RATional choice for translational research?Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches.Behavioral control by striatal adenosine A2A -dopamine D2 receptor heteromers.Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression.Adenosine A2A-dopamine D2 receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics.Oligomerization of a G protein-coupled receptor in neurons controlled by its structural dynamics.PBF509, an Adenosine A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism

P2860

Q33687719-3C3F4133-2E54-4C3B-9EA5-7600B438ADE8 Q36171090-1A487DED-23F0-4C9B-AEAF-B35458A9338A Q37489251-4C3EBDF1-C719-49E8-9424-26F1FE00E779 Q38618328-3D88A137-6CEA-4727-9F70-CB8C2C411787 Q40850213-F1311E0E-1F1D-4432-8749-63D59A0F23AA Q41534391-45C8818D-FDDE-48BC-8EC5-43966CB20701 Q42372900-ADE9B58D-3697-43CB-B761-8B9E1DDE6361 Q42377330-7B5D2606-128C-4A3F-9992-A943F46C4A4A Q47137101-A2F53002-3968-458B-ADF2-1C64E25B4510 Q47624646-2C40442A-7B8A-4E35-ABF1-75614FB06BA0 Q47988327-5B2B7957-8BAF-4B9C-A98F-9A0B5E8DBF5E Q53825616-5665631C-3D1E-4C6B-B20A-B3C7C5AD9971 Q55666818-544A1C6F-AA4D-4230-9CBB-5C5AF149601C Q58587583-56BE8F70-F33F-4FC3-BC47-6DB52EF693BF Q58697812-2B9159F1-3C35-4683-8DEC-BC5AF3DB9167

P2860

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats

http://www.wikidata.org/entity/Q34818322

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@ast

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@en

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@nl

type

label

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@ast

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@en

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@nl

prefLabel

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@ast

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@en

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@nl

P1433

Q34818322-B770C5BF-AF0A-4C57-976F-C6B99DB3DB1B

P1476

Q34818322-89ADBFB9-4B22-4097-B197-70B235BA8AFF

P2093

Q34818322-1A5EA7B6-C11A-4041-B9E0-8A6D0FAAAAAF

Q34818322-22097766-D804-4729-BCF3-9C815B93CBCF

Q34818322-69765394-51CE-447D-8AE1-E1CB73844DD1

Q34818322-6AA5276B-A6E0-4A52-85CF-95D596A12EC5

Q34818322-6C5CE6C6-8C44-48E6-BC42-01EB6E910320

Q34818322-9FF1B515-E63D-46B0-8846-CBEEA4E92E5A

Q34818322-BE28E2E0-45EE-4571-BD6A-E7C53107C475

Q34818322-C2E3171C-265A-48B7-B50F-C19C39214C41

Q34818322-DD7623EB-6996-4221-86F3-CA91933A5EFE

P2860

Q34818322-0FB6EEE2-C2D0-419A-B6C7-92A8428E9255

Q34818322-10C53BEA-3B79-43FF-A923-9F8CCD388A52

Q34818322-137B6BE1-31B2-441E-8CA1-73B7DF4CF36F

Q34818322-13B07E01-CD22-4E30-823E-53C73FC94E85

Q34818322-226443E0-02FA-4072-9CDC-BB81B7CB47D7

Q34818322-23ACAB1D-8F37-4B4B-90E6-0085A850469E

Q34818322-2810870B-5238-4C4E-B9C4-A51B57D5DC7B

Q34818322-2FF5BCA7-D018-4BED-92D3-BDF4543A6AFC

Q34818322-3850EF9F-CCBB-487E-8E53-F8C972BEAE67

Q34818322-40F98CDA-8F1B-4BC8-AB4D-5EB5F8C4C0A5

P304

Q34818322-491BD177-A894-4CC4-9612-770E3D34C2C0

P31

Q34818322-950BFC20-0B52-4DD2-B2ED-432B8915B72A

P356

Q34818322-70DB4956-490D-4ECA-A547-65069017B31F

P433

Q34818322-E23A157E-AD85-431F-B82F-7FE2A884D5FD

P478

Q34818322-09F672A5-37EB-4697-B70F-3D078EEEABDE

P50

Q34818322-172F7F97-91D5-4BC0-8913-631A51608907

Q34818322-F02DABC9-6748-4827-9617-E9F12847DEC1

Q34818322-F13AA591-CADF-4A55-90FF-D64AC7E80A44

P577

Q34818322-5D8D28F5-109D-4460-B0A0-387B231516AE

P5875

Q34818322-DCCB0059-73EF-439C-A673-38EE6C66EEF7

P698

Q34818322-A7A9F896-329D-4EDB-93C9-7094F829C050

P921

Q34818322-1A2E94EB-461A-4054-A0EE-11ADAF36E028

P932

Q34818322-85183861-EECC-48C9-AC38-65E695E23691

P356

P1433

Disease Models & Mechanisms

P1476

Untangling dopamine-adenosine ...... erimental parkinsonism in rats

@en

P2093

Catherine Ledent

http://www.w3.org/2001/XMLSchema#string

Eric Trinquet

http://www.w3.org/2001/XMLSchema#string

Francisco Ciruela

http://www.w3.org/2001/XMLSchema#string

Jaume J Taura

http://www.w3.org/2001/XMLSchema#string

Marc López-Cano

http://www.w3.org/2001/XMLSchema#string

Martin Cottet

http://www.w3.org/2001/XMLSchema#string

Masahiko Watanabe

http://www.w3.org/2001/XMLSchema#string

Rafael Luján

http://www.w3.org/2001/XMLSchema#string

Víctor Fernández-Dueñas

http://www.w3.org/2001/XMLSchema#string

P2860

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

Recent developments in adenosine receptor ligands and their potential as novel drugs

Oligomerization of adenosine A2A and dopamine D2 receptors in living cells

Characterization of the Potent and Highly Selective A(2A) Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyraz olo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of

Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons.

Lighting up multiprotein complexes: lessons from GPCR oligomerization

Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function.

P304

57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/DMM.018143

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Durroux

Jean-Philippe Pin

Martha Maricel Gómez Soler

P577

2014-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268336178

http://www.w3.org/2001/XMLSchema#string

P698

25398851

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4283650

http://www.w3.org/2001/XMLSchema#string